团结实验
| 系列条目索引 |
| 2019冠状病毒病疫情 |
|---|
 |
|
.svg){kind=small} 2019冠狀病毒病主题 |
团结实验（Solidarity trial）是由世界卫生组织和合作伙伴進行的一项多国III-IV期临床试验，旨在比较四种未经测试的2019冠状病毒病治疗方法。该试验于2020年3月18日正式對外宣布[1]，2020年5月，世卫组织宣布成立一个国际联盟，負責同时开发多种候选疫苗以预防2019冠状病毒病，并将这项工作称为疫苗团结试验。 [2]截至2021年8月6日，已經有來自30个国家的12000名患者参与团结实验[3]。
参考文献
- ^ UN health chief announces global 'solidarity trial' to jumpstart search for COVID-19 treatment. United Nations, World Health Organization. 18 March 2020 [2 April 2020]. （原始内容存档于2020-03-23） （英语）.
- ^ Update on WHO Solidarity Trial – Accelerating a safe and effective COVID-19 vaccine. World Health Organization. 2020-04-27 [2020-05-02]. （原始内容存档于2020-04-24）.
It is vital that we evaluate as many vaccines as possible as we cannot predict how many will turn out to be viable. To increase the chances of success (given the high level of attrition during vaccine development), we must test all candidate vaccines until they fail. WHO is working to ensure that all of them have the chance of being tested at the initial stage of development. The results for the efficacy of each vaccine are expected within three to six months and this evidence, combined with data on safety, will inform decisions about whether it can be used on a wider scale
- ^ 'Solidarity' clinical trial for COVID-19 treatment. www.who.int. World Health Organization. [2020-04-22]. （原始内容存档于2020-10-12） （英语）.